$TWST News

Twist Bioscience Corporation (TWST) Analyst/Investor Day Transcript

Twist Bioscience Corporation (TWST) Analyst/Investor Day - Slideshow

LenioBio GmbH Partners With Twist Bioscience To Integrate Its ALiCE Platform With Twist's DNA Production, Automation Tools

Twist Bioscience: AI Momentum Is Real, But The Easy Money Has Been Made

These Analysts Boost Their Forecasts On Twist Bioscience After Q2 Results

Leerink Partners Upgrades Twist Bioscience to Outperform, Announces $70 Price Target

Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $65

Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $60

Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $65

Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call Transcript

AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens

Twist Bioscience TWST Q2 Fiscal 2026: Revenue Beat Offset by Wider EPS Miss

Twist Bioscience Corporation 2026 Q2 - Results - Earnings Call Presentation

Twist Bioscience Q2 2026 Earnings Call Transcript

Twist Bioscience Q2 Adj. EPS $(0.59) Misses $(0.48) Estimate, Sales $110.715M Beat $107.657M Estimate

Twist Bioscience Sees Q3 Sales $114.000M-$115.000M vs $111.371M Est

Twist Bioscience Expands Clonal Genes Portfolio With Early Access Launch Of Complex Genes

Twist Bioscience Raises FY2026 Sales Guidance from $435.000M-$440.000M to $442.000M-$447.000M vs $439.118M Est

Evercore ISI Group Maintains Outperform on Twist Bioscience, Raises Price Target to $56

Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $55